If you are anything like the curmudgeonly crew at BuyersStrike! HQ you probably try to keep a list, mental or otherwise, of all of the ridiculous claims made by everybody’s favorite pink sheet reverse-merger Coronacrapper, Cytodyn (CYDY). Oftentimes these exaggerated plans deal with very specific countries which seem to flit in and out of press releases with little rhyme or reason.
One of those countries, as you might remember from the Spring of 2021, is Canada. Don’t recall The NaDDiR* hyping up Canada as a potential EUA and even as a revenue source for loserlimab? Of course you do. Here’s a mention from an early March, 2021 webcast:
Not only will CYDY file for an Interim Order, the Canadian equivalent of an Emergency Use Authoriziation, but The NaDDiR* went as far as to suggest they might charge for loserlimab. This was quickly followed up in a conference call later in March:
So, as of March 23, 2021, the company has submitted a timeline to Health Canada, to start the Interim Order process. The NaDDir* gives an update about two weeks later:
Here he claims that on the 15th of April they will submit the necessary paperwork for the Interim Order, and again suggests they might be able to sell product in Canada.
On the 19th of April, Cytodyn announces that it has submitted part, and only part, of the Interim Order application. In a press release the company stated that the remaining sections would be submitted in the very near future:
Two or so weeks later, on another webcast, The NaDDiR* claims the submission could be finished by June, with a decision in July. Now he isn’t so sure they can sell loserlimab, but he promises to ask:
And since then, nothing but crickets from Cytodyn and its Klown Krew about getting an IO, let alone selling product, in Canada?
Dear readers, do you wonder why?
Surprising nobody with an IQ to the right of the median, the request for the Interim Order with Health Canada expired after six months because Cytodyn never completed the application for loserlimab! No actual complete submission was ever made. Sound familiar?
So what did the company actually submit to Health Canada?
See it all for yourself right here. The company knew at least by June 15, 2021 that they would not get an Interim Order from Health Canada, and that the clinical data to support any application would not actually be available until the very end of this year. Did The NaDDiR* ever tell you?
Or did he just pivot to the next country? Brazil? India? Philippines?
* Spelled Thusly For A Double Dose of That Sweet Sweet Stock Pimping
THE CONTENT CONTAINED IN THIS BLOG REPRESENTS ONLY THE OPINIONS OF THE AUTHOR. THE AUTHOR MAY HOLD EITHER LONG OR SHORT POSITIONS IN SECURITIES OF VARIOUS COMPANIES DISCUSSED IN THE BLOG. THIS COMMENTARY IN NO WAY CONSTITUTES INVESTMENT ADVICE, AND SHOULD NEVER BE RELIED ON IN MAKING AN INVESTMENT DECISION, EVER. THIS BLOG IS NOT A SOLICITATION OF BUSINESS: ALL INQUIRIES WILL BE IGNORED. THE CONTENT HEREIN IS INTENDED SOLELY FOR THE ENTERTAINMENT OF THE READER, AND THE AUTHOR.
I don’t understand why the SEC and DOJ is taking so long with their investigations. By now they should have more than enough data to move in on the company. Many naive retail investors are losing money investing in this junk.
SEC doesn’t work fast, but they are thorough. They have a lot of company paid ghost writers of “investor” articles, paid social media posters and then all the stock pumping press release that were clearly deceptive. Then there is the insider stock trading by both NP (April 30, 2020) and Dr. Kelly (around the CD12 data release).
One other event occurred in the same time period — NP and his insider buddies filed for a secondary and sold their stock on April 30, 2020. NP cashed out ~$15 million, about 85% of his options while he was hyping the “complete” BLA filing. Classic pump and dump. We’ll see if the SEC digs that deep in their investigation but the Amarex putting out that NP email should be quite a smoking gun.
I would have thought that the first and most obviously actionable thing would be the false BLA complete P R ,followed by the insider trading. I mean by this ,that if the sec don’t dig deep enough for that ,then the investigation can’t be very significant . Will be outrageous if management get away with their actions. In any case , despite having made a nice profit ,I will never invest or gamble,if you like ,in OTC stocks . One thing they all seem to have in common is …no independent board of directors.